Shares of Zotefoams plc (LON:ZTF – Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 416.04 ($5.21) and traded as low as GBX 315 ($3.94). Zotefoams shares last traded at GBX 315 ($3.94), with a volume of 14,643 shares traded.
Zotefoams Stock Performance
The stock has a fifty day moving average of GBX 343.15 and a 200-day moving average of GBX 416.04. The firm has a market capitalization of £153.09 million, a P/E ratio of 1,575.00, a P/E/G ratio of 0.66 and a beta of 1.40. The company has a quick ratio of 0.67, a current ratio of 1.30 and a debt-to-equity ratio of 43.67.
Insider Transactions at Zotefoams
In other news, insider Ronan Cox bought 3,204 shares of the stock in a transaction that occurred on Monday, December 23rd. The shares were acquired at an average cost of GBX 310 ($3.88) per share, for a total transaction of £9,932.40 ($12,429.48). Company insiders own 18.96% of the company’s stock.
Zotefoams Company Profile
Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polyolefin block foams in the United Kingdom, rest of Europe, North America, and internationally. The company operates through Polyolefin Foams, High-Performance Products, and MuCell Extrusion LLC segments. It offers AZOTE, a polyolefin foam under the Plastazote, Evazote, and Supazote, AZOTE Adapt brands; and various high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK brand; and Ecozote foam for plastic products that offers circularity and reduce reliance on fossil fuel-derived raw materials.
Further Reading
- Five stocks we like better than Zotefoams
- How to Calculate Inflation Rate
- 3 Stocks Helping to Bring AI to Healthcare
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 3 Stocks Ringing in The New Year With Large Buyback Announcements
- Investing in the High PE Growth Stocks
- Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better
Receive News & Ratings for Zotefoams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zotefoams and related companies with MarketBeat.com's FREE daily email newsletter.